Sector Expert: Stephen O'Neil

Hilliard Lyons



Recent Quotes

"JNJ's Q2/13 revenue rose 9% from Q2/12 and was $200M above expectations."

— Stephen O'Neil, Hilliard Lyons (7/16/13)
more >

"Double-digit growth in pharmaceuticals and medical devices contributed to higher Q1 sales for JNJ."

— Stephen O'Neil, Hilliard Lyons (4/17/13)
more >

"We rate JNJ a long term Buy."

— Stephen O'Neil, Hilliard Lyons (10/16/12)
more >

"JNJ's first quarter earnings exceeded consensus estimates."

— Stephen O'Neil, Hilliard Lyons (4/17/12)
more >



Due to permission requirements, not all quotes are shown.